Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Points can sometimes offer greater rewards than cash back. Learn when to choose points to maximize your financial advantages.
27,793 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
The POWI 2026 earnings transcript sheds light on how the company performed in Q1 and what the path ahead could look l...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
A new Medicare bridge program could lower GLP-1 drug bills to about $50 a month for eligible seniors. Here’s what you...
Verizon sits near a 52-week high while AT&T hovers around a key level near $23, prompting renewed investor scrutiny o...
In a higher-rate environment, CDL continues to deliver a reliable monthly cash stream with a $2.29 per-share annual d...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...
Nvidia has built a fortress around AI-driven growth, but one number could alter the trajectory. This article breaks d...
Bitcoin has tumbled from its peak while gold shines in volatile times. Could a monster rally lift BTC to $150,000 by ...
A single wall street analyst thinks Tilray could deliver a sizable rally in the coming weeks. This article breaks dow...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...